# Carbidopa and Levodopa

NDC: 69367-340
Generic name: Carbidopa and Levodopa
Labeler / Manufacturer: Westminster Pharmaceuticals, LLC
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: Abbreviated NDA (generic)
Dosage form: TABLET
Routes: ORAL
Marketing started: 20210930

FDA application: ANDA214092

## Active ingredients

- CARBIDOPA: 25 mg/1
- LEVODOPA: 250 mg/1

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"69367-340"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=69367-340
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=3f026272-32a6-4c98-8b6f-d910c7f58aa2
